Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor

Name
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor
Accession Number
DBCAT003504
Description
Not Available
Drugs
DrugDrug Description
SofosbuvirA direct-acting antiviral agent used to treat specific hepatitis C virus (HCV) infections in combination with other antiviral agents.
Drugs & Drug Targets
DrugTargetType
SofosbuvirP-glycoprotein 1transporter
SofosbuvirATP-binding cassette sub-family G member 2transporter
SofosbuvirRNA-dependent RNA-polymerasetarget
SofosbuvirLysosomal protective proteinenzyme
SofosbuvirCarboxylesteraseenzyme
SofosbuvirHistidine triad nucleotide-binding protein 1enzyme
SofosbuvirUMP-CMP kinaseenzyme
SofosbuvirNucleoside diphosphate kinase Aenzyme